Published in Cancer Weekly, August 24th, 1998
M.C. Esandi and colleagues from Leiden University, IntroGene BV, and Pathologisch Laboratorium, The Netherlands, established a new method of anticancer cytokine gene therapy using lysed adenoproducer cells ("IL-1/IL-3 Gene Therapy of Non-Small Cell Lung Cancer (NSCLC) in Rats Using 'Cracked' Adenoproducer Cells," Gene Therapy, June 1998;5(6):778-88).
"In this study, we explored the potential of the cytokines interleukin (IL)-1(alpha) and IL-3(beta) to trigger a systemic antitumor response," stated Esandi et al. "We have been able to induce...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-08-24)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.